BR9302386A - Composition containing fractions of leishmania cells, called FML antigen "fucose mannose ligand" or "fucose-mannose ligand", use of FML antigen and its subfractions and components for specific immunodiagnosis of human and animal visceral leishmaniasis, for applications in vaccination, treatment or immunotherapy against human and canine visceral leishmaniasis - Google Patents
Composition containing fractions of leishmania cells, called FML antigen "fucose mannose ligand" or "fucose-mannose ligand", use of FML antigen and its subfractions and components for specific immunodiagnosis of human and animal visceral leishmaniasis, for applications in vaccination, treatment or immunotherapy against human and canine visceral leishmaniasisInfo
- Publication number
- BR9302386A BR9302386A BR9302386A BR9302386A BR9302386A BR 9302386 A BR9302386 A BR 9302386A BR 9302386 A BR9302386 A BR 9302386A BR 9302386 A BR9302386 A BR 9302386A BR 9302386 A BR9302386 A BR 9302386A
- Authority
- BR
- Brazil
- Prior art keywords
- fucose
- visceral leishmaniasis
- human
- mannose ligand
- antigen
- Prior art date
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR9302386A BR9302386A (en) | 1993-06-17 | 1993-06-17 | Composition containing fractions of leishmania cells, called FML antigen "fucose mannose ligand" or "fucose-mannose ligand", use of FML antigen and its subfractions and components for specific immunodiagnosis of human and animal visceral leishmaniasis, for applications in vaccination, treatment or immunotherapy against human and canine visceral leishmaniasis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR9302386A BR9302386A (en) | 1993-06-17 | 1993-06-17 | Composition containing fractions of leishmania cells, called FML antigen "fucose mannose ligand" or "fucose-mannose ligand", use of FML antigen and its subfractions and components for specific immunodiagnosis of human and animal visceral leishmaniasis, for applications in vaccination, treatment or immunotherapy against human and canine visceral leishmaniasis |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9302386A true BR9302386A (en) | 1995-01-17 |
Family
ID=4056688
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9302386A BR9302386A (en) | 1993-06-17 | 1993-06-17 | Composition containing fractions of leishmania cells, called FML antigen "fucose mannose ligand" or "fucose-mannose ligand", use of FML antigen and its subfractions and components for specific immunodiagnosis of human and animal visceral leishmaniasis, for applications in vaccination, treatment or immunotherapy against human and canine visceral leishmaniasis |
Country Status (1)
Country | Link |
---|---|
BR (1) | BR9302386A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6423529B1 (en) | 1997-12-08 | 2002-07-23 | Council Of Scientific & Industrial Research | Composition useful for the early diagnosis of visceral leishmaniasis and a process for preparing the same |
WO2008009088A2 (en) | 2006-07-21 | 2008-01-24 | Universidade Federal De Minas Gerais | Vaccine composition and immunization method |
-
1993
- 1993-06-17 BR BR9302386A patent/BR9302386A/en not_active Application Discontinuation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6423529B1 (en) | 1997-12-08 | 2002-07-23 | Council Of Scientific & Industrial Research | Composition useful for the early diagnosis of visceral leishmaniasis and a process for preparing the same |
WO2008009088A2 (en) | 2006-07-21 | 2008-01-24 | Universidade Federal De Minas Gerais | Vaccine composition and immunization method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL940016I1 (en) | Human factor viii compositions containing these methods and materials for use in their preparation | |
NO20001104L (en) | Humanized antibodies to human gp39, compositions containing such, and therapeutic uses thereof | |
BR9610248A (en) | Compound pharmaceutical composition processes for the treatment of pain and for the preparation of a compound and use of the compound | |
BR9100360A (en) | COMPOSITION FOR SKIN CARE | |
US4529588A (en) | Hair conditioning shampoo | |
BR9609532A (en) | Antimicrobial composition for the treatment of hair process for the treatment of dandruff and use of the composition | |
MA21488A1 (en) | COMPOSITIONS FOR DARKING NATURAL FIBERS AND APPLICATION TO HUMAN HAIR. | |
IT1285002B1 (en) | PESTICIDE COMPOSITION FOR THE TREATMENT AND PROTECTION OF PETS | |
BR9405669A (en) | Powder composition to bleach hair or keratinous fiber and method of preparation and use thereof | |
BR9612309A (en) | Compound use of a compound pharmaceutical composition aerosol combination pharmaceutical formulation and processes for the treatment of a human or animal individual with an anti-inflammatory and / or allergic condition and for the preparation of a compound | |
AR228245A1 (en) | 3- (2,2-DIHALOETHENYL) -2,2-DIMETHYLCLOPROPANOCARBOXYLATE, EXCEPT WHEN INTENDED FOR APPLICATION ON OR IN MAN AND HIGHER ANIMALS; PESTICIDE FORMULATION BASED ON SUCH A COMPOUND; AND A COMPOUND OF (1,1-BIPHENYL) -3-SUBSTITUTED ILMETILO INTENDED EXCLUSIVELY AS AN INTERMEDIARY FOR THE PREPARATION OF SUCH COMPOUND | |
BR9510509A (en) | Compound pharmaceutical or cosmetic composition Use of a composition and process to prevent and / or combat skin aging | |
BR8204174A (en) | DYEING SYSTEM AND COMPOSITION FOR HUMAN HAIR | |
DK295190D0 (en) | COSMETICS AND SKIN TREATMENT COMPOSITIONS | |
BR9300133A (en) | BINDING AGENT FOR WIRE AND BELT COATING COMPOUNDS | |
BR9710376A (en) | Antiviral compound use of the same pharmaceutical composition and process for prophylactic or therapeutic antiviral treatment of a human or non-human animal | |
BR9602680A (en) | Use of a skin care composition and skin care agent | |
BR9302386A (en) | Composition containing fractions of leishmania cells, called FML antigen "fucose mannose ligand" or "fucose-mannose ligand", use of FML antigen and its subfractions and components for specific immunodiagnosis of human and animal visceral leishmaniasis, for applications in vaccination, treatment or immunotherapy against human and canine visceral leishmaniasis | |
IT8667916A0 (en) | COMPOSITE POWDER PROCEDURE FOR ITS PREPARATION AND ITS USE PARTICULARLY IN COSMETIC PRODUCTS | |
BR9509750A (en) | Compound processes for their preparation and for controlling animal pests or harmful fungi composition against animal pests or harmful fungi and use of compounds | |
IT1224574B (en) | ACTUATION FACTOR OF NEUTROFILE LEUKOCYTES, PREPARATION PROCEDURE, AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT | |
FR2725367B1 (en) | COSMETIC COMPOSITION COMPRISING A FILM-FORMING POLYMER AND A SILICONE COMPOUND | |
IT8621439A0 (en) | COMPOSITION FOR LOCAL USE WITH VITA' SPERMICIDAL, VIRULICIDAL, DISINFECTANT AND/OR BACTERICIDE ACTS | |
IT1266950B1 (en) | OILY PREPARATION CONTAINING ANTIOXIDANT SUBSTANCES FOR HUMAN USE AND PROCEDURE FOR ITS PRODUCTION | |
BR8207145A (en) | COSMETIC COMPOSITION FOR SKIN TREATMENT OR HAIR TREATMENT, PROCESS FOR MANUFACTURING COMPOUNDS, PROCESS FOR MANUFACTURING SUCH COSMETIC COMPOSITION, PROCESS FOR TREATING HAIR OR SKIN AND COMPOUND USE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Application withdrawn |